By Manufacturing Process

Fermentation (Microbial / Fungal) Market Analysis

Cross-industry research covering Fermentation (Microbial / Fungal) across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Fermentation (Microbial / Fungal)

Hospital Acquired Infection Control Market to Reach USD 41.6B by 2033 at 6.4% CAGR

Pharmaceuticals·Market: USD 25.3 Billion (2025)·CAGR: 6.4%

The majority of beta-lactam APIs, including penicillins and cephalosporins, and glycopeptides are produced via fermentation at scale. Fermentation capacity is concentrated in China and India, creating supply-chain concentration risk that FDA CDER has flagged in drug shortage notices. ICH Q11 development and manufacture of drug substances guidance governs the biologics-adjacent fermentation processes in this segment.

35%

Market Share

5.8%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments